|
09:00 - 09:25
|
The Access Platform : a collaborative way to progress early drug discovery projects - Dr. Claudine Grepin |
|
|
09:25 - 09:50
|
Generation of germline mutations using ZFN TALE nuclease technology - Pr. Wolfgang Wurst |
|
|
09:50 - 10:15
|
Spatio-temporally-controlled targeted somatic mutagenesis in the mouse - Dr. Daniel Metzger |
|
|
10:15 - 10:35
|
Mouse models for gene therapy of inherited muscular disorders - Dr. Ana Buj-Bello |
|
|
10:35 - 11:00
|
Coffee break |
|
|
11:00 - 11:25
|
The IKMC Web Portal: a single access point to mouse knockouts from the International Knockout Mouse Consortium - Dr. Bill Skarnes |
|
|
11:25 - 11:50
|
The contribution of mice models toward a cell therapy for diabetes - Dr Gerard Gradwohl |
|
|
11:50 - 12:15
|
The International Mouse Phenotyping Consortium - Pr. Steve Brown |
|
|
12:15 - 13:40
|
Lunch |
|
|
13:40 - 14:05
|
Opioid receptors and neural disorders: genetic approaches in mice - Dr. Brigitte Kieffer |
|
|
14:05 - 14:20
|
Non viral siRNA delivery for cancer treatment - Dr. Anne Laure Bolcato-Bellemin |
|
|
14:20 - 14:45
|
Segmentation of the mouse embryo - Dr. Olivier Pourquié |
|
|
14:45 - 15:00
|
Correlation of Anatomical Features and Molecular Information by MSI and MRI - Dr. Michael Becker |
|
|
15:00 - 15:25
|
Genetic dissection of the molecular and cellular bases of adaptive immunity: from mouse to human. - Dr. Bernard Malissen |
|
|
15:25 - 16:00
|
Coffee break |
|
|
16:00 - 16:10
|
The genesis of transgenic mice in Strasbourg - Dr. Marianne LeMeur |
|
|
16:10 - 16:20
|
From ES to MCI (ICS) - Dr. Andrée Dierich |
|
|
16:20 - 16:40
|
PHENOMIN, the way forward - Dr. Yann Hérault |
|
